mechanism of action of semaglutide absorption and protection the molecule [38, Semaglutide as a Cornerstone Therapy

Here is what the company publishes, along with broader market context

Risks of Improper IGF-1 LR3 Dosing Because IGF-1 stimulates growth pathways, excessive or unsupervised dosing may increase risks, including: Hypoglycemia (low blood sugar) Edema Joint discomfort Nerve compression symptoms Potential overstimulation of mitogenic pathways IGF-1 signaling is also involved in cellular proliferation

Chen J, Kang B, Jiang Q, et al

The plasma half-life is estimated at 30-60 minutes, though biological effects on gene expression persist for hours to days

It is effective in the treatment of obesity in patients with and without DM

In addition, the reduction in GI symptoms associated with the LFD was linked to a decrease in pain and functional impact [34], suggesting a possible connection between these symptoms and changes in the intestinal microbiota